F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatitis C virus

1	Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus 4/4/2018 1:15:45 PM \| Browse: 65 \| Download: 12
2	Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus 3/26/2018 8:48:04 AM \| Browse: 61 \| Download: 28
3	Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release 3/26/2018 8:48:04 AM \| Browse: 39 \| Download: 9
4	Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions 3/16/2018 12:27:25 PM \| Browse: 62 \| Download: 12
5	Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents 3/4/2018 12:36:47 PM \| Browse: 43 \| Download: 15
6	Hepatitis C virus: Morphogenesis, infection and therapy 3/4/2018 12:36:47 PM \| Browse: 51 \| Download: 15
7	High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016 1/26/2018 8:09:36 AM \| Browse: 89 \| Download: 31
8	Role of inflammatory response in liver diseases: Therapeutic strategies 1/26/2018 8:09:36 AM \| Browse: 78 \| Download: 22
9	Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates 1/19/2018 9:46:49 AM \| Browse: 106 \| Download: 29
10	Hepatitis C virus core protein-induced miR-93-5p inhibits IFN signaling pathway through targeting IFNAR1 1/14/2018 5:07:58 AM \| Browse: 83 \| Download: 69
11	Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas 1/7/2018 4:21:05 AM \| Browse: 92 \| Download: 30
12	Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet? 1/7/2018 4:21:04 AM \| Browse: 86 \| Download: 27
13	Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection 12/27/2017 10:31:19 AM \| Browse: 99 \| Download: 34
14	Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b 12/12/2017 8:34:13 AM \| Browse: 92 \| Download: 34
15	Global elimination of hepatitis C virus infection: Progresses and the remaining challenges 11/24/2017 12:22:15 AM \| Browse: 138 \| Download: 42
16	Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection 8/28/2017 6:54:48 AM \| Browse: 160 \| Download: 221
17	(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes 8/28/2017 6:54:48 AM \| Browse: 128 \| Download: 167
18	Lurking epidemic of hepatitis C virus infection in Iran: A call to action 8/25/2017 1:53:29 AM \| Browse: 120 \| Download: 115
19	Direct-acting antiviral agents against hepatitis C virus and lipid metabolism 8/19/2017 11:33:53 AM \| Browse: 87 \| Download: 130
20	Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model 7/28/2017 8:16:18 AM \| Browse: 109 \| Download: 589
21	Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study 7/17/2017 11:13:33 PM \| Browse: 103 \| Download: 161
22	Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease 7/5/2017 4:40:07 AM \| Browse: 131 \| Download: 265
23	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 411 \| Download: 1182
24	Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients 5/12/2017 10:16:48 PM \| Browse: 164 \| Download: 423
25	Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection 4/13/2017 3:45:15 PM \| Browse: 167 \| Download: 299
26	Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients 4/13/2017 3:45:15 PM \| Browse: 186 \| Download: 222
27	Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients 3/24/2017 9:18:00 AM \| Browse: 277 \| Download: 536
28	Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data 3/13/2017 7:05:00 PM \| Browse: 247 \| Download: 322
29	Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C 3/13/2017 1:20:00 PM \| Browse: 208 \| Download: 468
30	Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review 3/6/2017 1:27:00 PM \| Browse: 281 \| Download: 358
31	Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease 2/26/2017 6:20:00 PM \| Browse: 257 \| Download: 697
32	Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment 2/26/2017 6:20:00 PM \| Browse: 202 \| Download: 289
33	Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data 2/17/2017 8:32:00 AM \| Browse: 213 \| Download: 203
34	Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection 2/6/2017 9:08:00 AM \| Browse: 186 \| Download: 356
35	Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies 1/22/2017 11:39:00 AM \| Browse: 212 \| Download: 510
36	PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis 1/6/2017 8:51:00 AM \| Browse: 428 \| Download: 915
37	<i>PNPLA3</i> polymorphism increases risk for and severity of chronic hepatitis C liver disease 12/15/2016 4:06:00 PM \| Browse: 386 \| Download: 429
38	Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C 12/6/2016 5:24:00 PM \| Browse: 142 \| Download: 261
39	Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 11/26/2016 6:56:00 PM \| Browse: 212 \| Download: 349
40	New real-time-PCR method to identify single point mutations in hepatitis C virus 11/18/2016 3:13:00 PM \| Browse: 221 \| Download: 1165
41	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 204 \| Download: 466
42	Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis 11/13/2016 5:46:00 PM \| Browse: 207 \| Download: 400
43	Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection 11/12/2016 1:33:00 PM \| Browse: 214 \| Download: 692
44	Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections 11/4/2016 10:35:00 AM \| Browse: 206 \| Download: 305
45	Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention 10/25/2016 8:46:00 AM \| Browse: 386 \| Download: 572
46	Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity 10/25/2016 8:46:00 AM \| Browse: 196 \| Download: 665
47	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 310 \| Download: 308
48	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 10/12/2016 2:18:00 PM \| Browse: 194 \| Download: 229
49	Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014 9/26/2016 8:04:00 AM \| Browse: 259 \| Download: 588
50	Predictive potential of <i>IL-28B</i> genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective 9/14/2016 11:03:00 AM \| Browse: 229 \| Download: 580

Page 1 of 6 ( 281 items )
<<
1
2
3
4
5
6
>>

1	Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus 4/4/2018 1:15:45 PM \| Browse: 65 \| Download: 12
2	Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus 3/26/2018 8:48:04 AM \| Browse: 61 \| Download: 28
3	Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release 3/26/2018 8:48:04 AM \| Browse: 39 \| Download: 9
4	Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions 3/16/2018 12:27:25 PM \| Browse: 62 \| Download: 12
5	Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents 3/4/2018 12:36:47 PM \| Browse: 43 \| Download: 15
6	Hepatitis C virus: Morphogenesis, infection and therapy 3/4/2018 12:36:47 PM \| Browse: 51 \| Download: 15
7	High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016 1/26/2018 8:09:36 AM \| Browse: 89 \| Download: 31
8	Role of inflammatory response in liver diseases: Therapeutic strategies 1/26/2018 8:09:36 AM \| Browse: 78 \| Download: 22
9	Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates 1/19/2018 9:46:49 AM \| Browse: 106 \| Download: 29
10	Hepatitis C virus core protein-induced miR-93-5p inhibits IFN signaling pathway through targeting IFNAR1 1/14/2018 5:07:58 AM \| Browse: 83 \| Download: 69
11	Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas 1/7/2018 4:21:05 AM \| Browse: 92 \| Download: 30
12	Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet? 1/7/2018 4:21:04 AM \| Browse: 86 \| Download: 27
13	Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection 12/27/2017 10:31:19 AM \| Browse: 99 \| Download: 34
14	Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b 12/12/2017 8:34:13 AM \| Browse: 92 \| Download: 34
15	Global elimination of hepatitis C virus infection: Progresses and the remaining challenges 11/24/2017 12:22:15 AM \| Browse: 138 \| Download: 42
16	Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection 8/28/2017 6:54:48 AM \| Browse: 160 \| Download: 221
17	(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes 8/28/2017 6:54:48 AM \| Browse: 128 \| Download: 167
18	Lurking epidemic of hepatitis C virus infection in Iran: A call to action 8/25/2017 1:53:29 AM \| Browse: 120 \| Download: 115
19	Direct-acting antiviral agents against hepatitis C virus and lipid metabolism 8/19/2017 11:33:53 AM \| Browse: 87 \| Download: 130
20	Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model 7/28/2017 8:16:18 AM \| Browse: 109 \| Download: 589
21	Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study 7/17/2017 11:13:33 PM \| Browse: 103 \| Download: 161
22	Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease 7/5/2017 4:40:07 AM \| Browse: 131 \| Download: 265
23	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 411 \| Download: 1182
24	Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients 5/12/2017 10:16:48 PM \| Browse: 164 \| Download: 423
25	Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection 4/13/2017 3:45:15 PM \| Browse: 167 \| Download: 299
26	Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients 4/13/2017 3:45:15 PM \| Browse: 186 \| Download: 222
27	Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients 3/24/2017 9:18:00 AM \| Browse: 277 \| Download: 536
28	Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data 3/13/2017 7:05:00 PM \| Browse: 247 \| Download: 322
29	Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C 3/13/2017 1:20:00 PM \| Browse: 208 \| Download: 468
30	Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review 3/6/2017 1:27:00 PM \| Browse: 281 \| Download: 358
31	Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease 2/26/2017 6:20:00 PM \| Browse: 257 \| Download: 697
32	Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment 2/26/2017 6:20:00 PM \| Browse: 202 \| Download: 289
33	Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data 2/17/2017 8:32:00 AM \| Browse: 213 \| Download: 203
34	Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection 2/6/2017 9:08:00 AM \| Browse: 186 \| Download: 356
35	Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies 1/22/2017 11:39:00 AM \| Browse: 212 \| Download: 510
36	PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis 1/6/2017 8:51:00 AM \| Browse: 428 \| Download: 915
37	<i>PNPLA3</i> polymorphism increases risk for and severity of chronic hepatitis C liver disease 12/15/2016 4:06:00 PM \| Browse: 386 \| Download: 429
38	Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C 12/6/2016 5:24:00 PM \| Browse: 142 \| Download: 261
39	Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 11/26/2016 6:56:00 PM \| Browse: 212 \| Download: 349
40	New real-time-PCR method to identify single point mutations in hepatitis C virus 11/18/2016 3:13:00 PM \| Browse: 221 \| Download: 1165
41	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 204 \| Download: 466
42	Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis 11/13/2016 5:46:00 PM \| Browse: 207 \| Download: 400
43	Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection 11/12/2016 1:33:00 PM \| Browse: 214 \| Download: 692
44	Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections 11/4/2016 10:35:00 AM \| Browse: 206 \| Download: 305
45	Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention 10/25/2016 8:46:00 AM \| Browse: 386 \| Download: 572
46	Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity 10/25/2016 8:46:00 AM \| Browse: 196 \| Download: 665
47	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 310 \| Download: 308
48	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 10/12/2016 2:18:00 PM \| Browse: 194 \| Download: 229
49	Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014 9/26/2016 8:04:00 AM \| Browse: 259 \| Download: 588
50	Predictive potential of <i>IL-28B</i> genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective 9/14/2016 11:03:00 AM \| Browse: 229 \| Download: 580